IO BIOTECH INC. - COM
1.0600
07-10月-24 15:59:55
15 分の遅延
株式
-0.0900
-7.83%
本日の幅
1.0600 - 1.1700
ISIN
N/A
ソース
NASDAQ
-
01 11 2023 08:30:00 提供 Nasdaq GlobeNewswire
-
23 10 2023 01:00:00 提供 Nasdaq GlobeNewswire
-
03 10 2023 16:30:00 提供 Nasdaq GlobeNewswire
-
12 9 2023 08:05:00 提供 Nasdaq GlobeNewswire
-
IO Biotech Announces Participation in Upcoming Investor Conferences
06 9 2023 08:35:00 提供 Nasdaq GlobeNewswire
-
IO Biotech Announces 2023 Second Quarter Results
11 8 2023 08:30:00 提供 Nasdaq GlobeNewswire
-
IO Biotech Appoints Heidi Hunter to its Board of Directors
11 8 2023 08:05:00 提供 Nasdaq GlobeNewswire
-
IO Biotech Announces Abstract Accepted for Poster Presentation at ESMO Congress 2023
08 8 2023 08:05:00 提供 Nasdaq GlobeNewswire
-
IO Biotech, Inc. Announces $75 Million Private Placement Financing
07 8 2023 08:30:12 提供 Nasdaq GlobeNewswire
-
28 7 2023 08:05:00 提供 Nasdaq GlobeNewswire
-
25 7 2023 16:05:00 提供 Nasdaq GlobeNewswire
-
18 7 2023 16:05:00 提供 Nasdaq GlobeNewswire
-
IO Biotech Announces Achievement of Significant Phase 3 Clinical Trial Recruitment Milestone
14 6 2023 08:00:01 提供 Nasdaq GlobeNewswire
-
01 6 2023 08:30:00 提供 Nasdaq GlobeNewswire
-
IO Biotech to Present at the Jefferies Healthcare Conference
30 5 2023 16:35:00 提供 Nasdaq GlobeNewswire
-
IO Biotech Announces 2023 First-Quarter Results
11 5 2023 16:05:01 提供 Nasdaq GlobeNewswire
-
IO Biotech Announces 2022 Fourth-Quarter and Year-End Results
14 3 2023 16:11:47 提供 Nasdaq GlobeNewswire
-
IO Biotech to Participate in March 2023 Investor Conferences
22 2 2023 07:00:00 提供 Nasdaq GlobeNewswire
-
IO Biotech Announces Appointment of Devin Smith as General Counsel
23 1 2023 08:00:01 提供 Nasdaq GlobeNewswire
-
IO Biotech Provides Business Update
09 1 2023 07:05:46 提供 Nasdaq GlobeNewswire